Form 8-K - Current report:
SEC Accession No. 0001140361-24-036279
Filing Date
2024-08-08
Accepted
2024-08-08 07:00:26
Documents
15
Period of Report
2024-08-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ef20033779_8k.htm   iXBRL 8-K 27269
2 EXHIBIT 99.1 ef20033779_ex99-1.htm EX-99.1 256039
6 image00001.jpg GRAPHIC 2446
  Complete submission text file 0001140361-24-036279.txt   449347

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA insm-20240808.xsd EX-101.SCH 3859
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE insm-20240808_lab.xml EX-101.LAB 21966
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE insm-20240808_pre.xml EX-101.PRE 16040
18 EXTRACTED XBRL INSTANCE DOCUMENT ef20033779_8k_htm.xml XML 4065
Mailing Address 700 US HIGHWAY 202/206 BRIDGEWATER NJ 08807
Business Address 700 US HIGHWAY 202/206 BRIDGEWATER NJ 08807 908-977-9900
INSMED Inc (Filer) CIK: 0001104506 (see all company filings)

EIN.: 541972729 | State of Incorp.: VA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30739 | Film No.: 241185940
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)